Elizabeth A. Cermak's most recent trade in Moleculin Biotech Inc was a trade of 10,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Nov. 4, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Moleculin Biotech Inc | Elizabeth A. Cermak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 10,000 | 14,668 | - | - | Stock option (right to buy) | |
| Moleculin Biotech Inc | Elizabeth A. Cermak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 15,000 | 70,000 | - | - | Stock option (right to buy) | |
| Moleculin Biotech Inc | Elizabeth A. Cermak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2022 | 23,333 | 40,000 | - | - | Stock option (right to buy) | |
| Moleculin Biotech Inc | Elizabeth A. Cermak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2022 | 15,000 | 55,000 | - | - | Stock option (right to buy) |